moxr0916
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2014 (NCT02219724)
Timeline
Indications
Mechanism of action
TNFSF4 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- moxr0916
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03029832 | Phase 2 | Apr 27, 2017 | Genentech, Roche |
| NCT02410512 | Phase 1 | Apr 24, 2015 | Genentech, Roche |
| NCT02219724 | Phase 1 | Aug 12, 2014 | Genentech, Roche |
Showing 3 of 3 trials
Page 1 / 1